Flynn Paul R's Form 4 filing
Dexcom Inc (DXCM) · filed Sep 13, 2021
- Accession no.
- 0001093557-21-000213
- Filed
- Sep 13, 2021
- Trade date
- Sep 9-10, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $756.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flynn Paul RCIK 0001850141 | Officer (EVP, Global Revenue) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 | Common Stock | SSaleDisposed | −743 | $541.36 | −$402,230.48 | 11,563 | Direct | |
| Sep 9, 2021 | Common Stock | SSaleDisposed | −9 | $541.76 | −$4,875.84 | 11,554 | Direct | |
| Sep 10, 2021 | Common Stock | SSaleDisposed | −626 | $558.33 | −$349,514.58 | 10,928 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.